Literature DB >> 3094935

Open pilot trial of ritanserin in parkinsonism.

A Maertens de Noordhout, P J Delwaide.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3094935     DOI: 10.1097/00002826-198610000-00010

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


× No keyword cloud information.
  8 in total

Review 1.  5-HT2 antagonism and EPS benefits: is there a causal connection?

Authors:  S Kapur
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 2.  Mechanisms of action of atypical antipsychotic drugs: a critical analysis.

Authors:  B J Kinon; J A Lieberman
Journal:  Psychopharmacology (Berl)       Date:  1996-03       Impact factor: 4.530

Review 3.  5-HT2A blockade for dyskinesia and psychosis in Parkinson's disease: is there a limit to the efficacy of this approach? A study in the MPTP-lesioned marmoset and a literature mini-review.

Authors:  Cynthia Kwan; Imane Frouni; Dominique Bédard; Stephen G Nuara; Jim C Gourdon; Adjia Hamadjida; Philippe Huot
Journal:  Exp Brain Res       Date:  2018-11-15       Impact factor: 1.972

4.  The effect of mirtazapine on dopaminergic psychosis and dyskinesia in the parkinsonian marmoset.

Authors:  Adjia Hamadjida; Stephen G Nuara; Nicolas Veyres; Imane Frouni; Cynthia Kwan; Lamia Sid-Otmane; Mery-Jane Harraka; Jim C Gourdon; Philippe Huot
Journal:  Psychopharmacology (Berl)       Date:  2017-01-27       Impact factor: 4.530

Review 5.  The serotonergic system in motor and non-motor manifestations of Parkinson's disease.

Authors:  Philippe Huot; Susan H Fox
Journal:  Exp Brain Res       Date:  2013-06-28       Impact factor: 1.972

6.  Effects of classical and novel agents in a MPTP-induced reversible model of Parkinson's disease.

Authors:  S P Close; P J Elliott; A G Hayes; A S Marriott
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

7.  Ritanserin, a 5-HT2 receptor antagonist, activates midbrain dopamine neurons by blocking serotonergic inhibition.

Authors:  L Ugedo; J Grenhoff; T H Svensson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 8.  DGKα in Neutrophil Biology and Its Implications for Respiratory Diseases.

Authors:  Gianluca Baldanzi; Mario Malerba
Journal:  Int J Mol Sci       Date:  2019-11-13       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.